Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Parkins

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Therapeutic Delivery|February 19, 2015
Tobramycin inhalation powder: an efficient and efficacious therapy for the treatment of Pseudomonas aeruginosa infection in cystic fibrosisRanjani Somayaji, Michael D Parkins
Seminars in Respiratory and Critical Care Medicine|January 9, 2023
Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and FutureChristina S Thornton, Michael D Parkins
Annals of the American Thoracic Society|May 1, 2024
STOP Using Corticosteroids in Cystic Fibrosis Pulmonary ExacerbationsMichael D Parkins, Christina S Thornton
Expert Review of Respiratory Medicine|July 28, 2010
Aztreonam lysine: a novel inhalational antibiotic for cystic fibrosisMichael D Parkins, J Stuart Elborn
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 2, 2016
Understanding the natural history and clinical implications of airways infections in CF - Moving beyond the classicsMichael D Parkins, Michael G Surette
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|May 5, 2009
Community-acquired Serratia marcescens spinal epidural abscess in a patient without risk factors: Case report and reviewMichael D Parkins, Daniel B Gregson
Expert Review of Respiratory Medicine|September 30, 2011
Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosisMichael D Parkins, J Stuart Elborn
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 18, 2015
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosisMichael D Parkins, R Andres Floto
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|December 11, 2013
Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Pseudomonas Aeruginosa Infection in Cystic FibrosisJohn Lam, Steven Vaughan, Michael D Parkins
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Rifampicin potentiation of aminoglycoside activity against cystic fibrosis isolates of Pseudomonas aeruginosaAlaya Mikalauskas, Michael D Parkins, Keith Poole
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Therapeutic Delivery|February 19, 2015
Tobramycin inhalation powder: an efficient and efficacious therapy for the treatment of Pseudomonas aeruginosa infection in cystic fibrosisRanjani Somayaji, Michael D Parkins
Seminars in Respiratory and Critical Care Medicine|January 9, 2023
Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and FutureChristina S Thornton, Michael D Parkins
Annals of the American Thoracic Society|May 1, 2024
STOP Using Corticosteroids in Cystic Fibrosis Pulmonary ExacerbationsMichael D Parkins, Christina S Thornton
Expert Review of Respiratory Medicine|July 28, 2010
Aztreonam lysine: a novel inhalational antibiotic for cystic fibrosisMichael D Parkins, J Stuart Elborn
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 2, 2016
Understanding the natural history and clinical implications of airways infections in CF - Moving beyond the classicsMichael D Parkins, Michael G Surette
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|May 5, 2009
Community-acquired Serratia marcescens spinal epidural abscess in a patient without risk factors: Case report and reviewMichael D Parkins, Daniel B Gregson
Expert Review of Respiratory Medicine|September 30, 2011
Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosisMichael D Parkins, J Stuart Elborn
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 18, 2015
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosisMichael D Parkins, R Andres Floto
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|December 11, 2013
Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Pseudomonas Aeruginosa Infection in Cystic FibrosisJohn Lam, Steven Vaughan, Michael D Parkins
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Rifampicin potentiation of aminoglycoside activity against cystic fibrosis isolates of Pseudomonas aeruginosaAlaya Mikalauskas, Michael D Parkins, Keith Poole
Pageof 12